Antonio M. Claparols, president of the Ecological Society of
the Philippines (ESP) yesterday discounted the benefits gained
from genetically modified rice.
The benefit of insect protection from Bt rice is offset by
the potential harmful effects of high levels of toxin protein
in the rice grain, Claparols said.
As rice is an important crop, the safety of Bt rice must be
concretely established, Claparols stressed. Studies have found
that food irradiation improved the quality of GM rice modified
with the Cry1Ab toxin by selectively removing the toxin protein.
However, study of the radiation products and adducts created
during destruction of the toxin is essential. Furthermore, it
is clear that food irradiation may be used to disguise GM rice.
Rice is the staple food crop for more than half of the world's
population, among them the poorest and is currently, the target
of genetic modification activity that has greatly intensified
after the rice genome was announced two years ago. Since then,
all major biotech giants are investing in rice research.
At the same time, a low-input cultivation system that really
benefits small farmers worldwide has been spreading, but is
dismissed by the scientific establishments as unscientific.
This is one among several innovations that increase yields and
ward off disease without costly and harmful inputs, all enthusiastically
and widely adopted by farmers.
Claparols reported that a war is building between the corporate
establishment and the peoples of the world for the possession
of rice. The food security of billions is at stake and as is
their right to grow the varieties of rice they have created
and continue to create, and in the manner they choose.
Such a crop of immense global importance is a certain target
for control by multinational companies, especially since the
rice genome was announced.
Pharm rice production of pharmaceutical proteins in rice crops
poses potent threats to the food supply. Recent efforts to test
and produce rice modified to produce the human gene products
lactoferin and lysozyme have been temporarily thwarted. However,
rice producing human growth hormone has been developed despite
the likelihood that GM rice could cause cancer in those consuming
it. Rice is not a suitable cross for producing pharmaceutical
products because of the high likelihood that the products will
pollute the food supply.